Dr. Robbie Barbero
From September 2012 to January 2017, Robbie worked in the White House Office of Science and Technology Policy where he developed and implemented policy on a wide range of global and national life science issues, including the BRAIN Initiative, the Precision Medicine Initiative, genome editing, reducing the organ transplant waiting list, agriculture innovation and entrepreneurship, developing world cancer diagnostics, biotechnology regulatory policy, and federal R&D agency budgets. Robbie is now the Chief Business Officer at Ceres Nanosciences, a small, venture-backed biotechnology company focused on the development and commercialization of innovative sample preparation products and diagnostic tests. Robbie has undergraduate and graduate degrees in biological engineering from Dartmouth and MIT. Between undergraduate and graduate school he spent five years working for three biotechnology startup companies in positions in quality control, process design, manufacturing, and customer support. At MIT, he worked in Angela Belcher's Biomolecular Materials Group on projects covering antimicrobial peptides, carbon capture, and industrial biocatalysts.